chr15-49860426-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024837.4(ATP8B4):c.3347G>A(p.Arg1116Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000328 in 1,613,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024837.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP8B4 | NM_024837.4 | c.3347G>A | p.Arg1116Gln | missense_variant | 28/28 | ENST00000284509.11 | NP_079113.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP8B4 | ENST00000284509.11 | c.3347G>A | p.Arg1116Gln | missense_variant | 28/28 | 5 | NM_024837.4 | ENSP00000284509 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250616Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135438
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461584Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727080
GnomAD4 genome AF: 0.000138 AC: 21AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.3347G>A (p.R1116Q) alteration is located in exon 28 (coding exon 27) of the ATP8B4 gene. This alteration results from a G to A substitution at nucleotide position 3347, causing the arginine (R) at amino acid position 1116 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at